[
  {
    "ts": null,
    "headline": "Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage",
    "summary": "Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage",
    "url": "https://finnhub.io/api/news?id=527f0381fd9b38a6903e003c1cf0d759cb50e54840ba6d0636dcbf55543da2b7",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740155631,
      "headline": "Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage",
      "id": 132835094,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage",
      "url": "https://finnhub.io/api/news?id=527f0381fd9b38a6903e003c1cf0d759cb50e54840ba6d0636dcbf55543da2b7"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.",
    "summary": "Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.",
    "url": "https://finnhub.io/api/news?id=235ac5bacbd5054f768167f7a55dae335a02ba6e95f7f9cab12e21ced9098138",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740152940,
      "headline": "Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.",
      "id": 132834762,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.",
      "url": "https://finnhub.io/api/news?id=235ac5bacbd5054f768167f7a55dae335a02ba6e95f7f9cab12e21ced9098138"
    }
  },
  {
    "ts": null,
    "headline": "American Century Ultra Fund Q4 2024 Commentary",
    "summary": "The reelection of former President Donald Trump initially pleased investors who had worried about another protracted legal battle regarding the electionâs results.",
    "url": "https://finnhub.io/api/news?id=28432d454250134095abc28e662127b36c52d783df7854ae725ef5757b7abdfa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740149520,
      "headline": "American Century Ultra Fund Q4 2024 Commentary",
      "id": 132829638,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1990350865/image_1990350865.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The reelection of former President Donald Trump initially pleased investors who had worried about another protracted legal battle regarding the electionâs results.",
      "url": "https://finnhub.io/api/news?id=28432d454250134095abc28e662127b36c52d783df7854ae725ef5757b7abdfa"
    }
  },
  {
    "ts": null,
    "headline": "US FDA says shortage of Novo's weight-loss drug resolved",
    "summary": "A shortage of Danish drugmaker NovoNordisk's popular weight-loss and diabetes drugs,Wegovy and Ozempic, has been resolved, the U.S. Food and DrugAdministration's website showed on Friday. ...",
    "url": "https://finnhub.io/api/news?id=2cd2f42ac512efc06252ed91a6db7de533a974cc94f100d14be6204c3561e3b3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740129175,
      "headline": "US FDA says shortage of Novo's weight-loss drug resolved",
      "id": 132827869,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "A shortage of Danish drugmaker NovoNordisk's popular weight-loss and diabetes drugs,Wegovy and Ozempic, has been resolved, the U.S. Food and DrugAdministration's website showed on Friday. ...",
      "url": "https://finnhub.io/api/news?id=2cd2f42ac512efc06252ed91a6db7de533a974cc94f100d14be6204c3561e3b3"
    }
  },
  {
    "ts": null,
    "headline": "JHML: Multi-Factor Vs. Single Factors",
    "summary": "John Hancock Multifactor Large Cap ETF uses a multifactor strategy but lags in returns. Learn why JHML underperforms compared to single factor ETFs.",
    "url": "https://finnhub.io/api/news?id=571944da1df00c9f38bfd1cb79e94f6d7f7a63c3dce83581dc5b9c18148b7b2d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740128886,
      "headline": "JHML: Multi-Factor Vs. Single Factors",
      "id": 132828003,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1694532155/image_1694532155.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "John Hancock Multifactor Large Cap ETF uses a multifactor strategy but lags in returns. Learn why JHML underperforms compared to single factor ETFs.",
      "url": "https://finnhub.io/api/news?id=571944da1df00c9f38bfd1cb79e94f6d7f7a63c3dce83581dc5b9c18148b7b2d"
    }
  },
  {
    "ts": null,
    "headline": "Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.",
    "summary": "Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.",
    "url": "https://finnhub.io/api/news?id=417b417b45f36e0d17949e0ae178bf714d721d462dbc58e6f972a9f56d5313da",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740120900,
      "headline": "Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.",
      "id": 132834633,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.",
      "url": "https://finnhub.io/api/news?id=417b417b45f36e0d17949e0ae178bf714d721d462dbc58e6f972a9f56d5313da"
    }
  }
]